To help expand your knowledge, we provide resources for further reading which can be viewed directly or downloaded for later.


Front cover image of the Forgotten Many SPMS burden report

The Forgotten Many: A 2020 vision for SPMS

Report detailing the impact of SPMS on patients and the healthcare system, putting forward a number of recommendations identified by a group of leading experts in the area, that can potentially help transform the delivery of SPMS care and patient outcomes.

This document contains links which will take you to external websites over which Novartis Pharmaceuticals UK Limited has no ownership or control. Novartis Pharmaceuticals UK Limited accepts no responsibility for the content, accuracy, or your use of linked websites.

Download resource

thumbnail image of Ophthalmology report cover

GIRFT ophthalmology report

The ophthalmology national report from the Getting It Right First Time (GIRFT) programme features 22 recommendations to improve units treating the major sight-threatening conditions, including cataract, glaucoma, wet age-related macular degeneration (wet AMD) and diabetic retinopathy.

View resource

Front cover image of Covid report

Rapid cardiovascular data: We need it now (and in the future)

The report explores how the collaborative approach to countering the impact of COVID-19 demonstrates the value of rapid analysis of national data in helping to improve outcomes for patients with cardiovascular disease.

View resource



front cover image of national heart failure audit

The National Heart Failure Audit 2020

The National Heart Failure Audit collects data on patients with an unscheduled admission to hospital in England and Wales who are discharged with a primary diagnosis of heart failure. The audit aims to drive up the quality of the diagnosis, treatment and management of heart failure by collecting, analysing and disseminating data, and eventually to improve mortality and morbidity outcomes for heart failure patients.

View resource


GIRFT, Getting It Right First Time; SPMS, secondary progressive multiple sclerosis.

Rate this content: 
No votes yet
UK | May 2021 | 121747

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]